Literature DB >> 9808175

Homing of mononuclear cells from iliac lymph nodes to the genital and rectal mucosa in non-human primates.

E A Mitchell1, L A Bergmeier, C Doyle, R Brookes, L A Hussain, Y Wang, T Lehner.   

Abstract

The route of immunization may affect the type of immunity that is induced. The objectives of this investigation were to establish in the non-human primate if the internal iliac lymph nodes (LN) function as an inductive site of immunity from which mononuclear cells home to the rectal and cervico-vaginal mucosa. Rhesus macaques were immunized with simian immunodeficiency virus (SIV) core antigen p27 in the proximity of the iliac lymph nodes, and compared with the intramuscular (i.m.) (deltoid or gluteal), and axillary LN routes of immunization. The macaques were then challenged rectally or vaginally by a particulate SIVp27 antigen which was applied to the mucosal surface. The tracking dye PKH26 was injected near the immunizing LN or i.m. site and a week later the mucosal and lymphoid tissues were examined at autopsy. Preferential homing of PKH26-labeled cells from the internal iliac LN to the rectal and vaginal mucosa was demonstrated by flow cytometry after targeted iliac LN (TILN) but not after intramuscular (deltoid) or axillary LN immunization. Homing of the subsets of cells revealed that labeled CD4, CD8 and B cells, as well as monocytes were found in the rectum, colon, vagina or cervix. The results of this investigation shows that the route of immunization may affect regional mucosal immunity. Furthermore, the internal iliac LN may function as an inductive immunological site from which CD4, CD8 and B cells may home preferentially to the rectal, cervical and vaginal mucosa, as well as to the related regional but not the unrelated distal LN.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808175     DOI: 10.1002/(SICI)1521-4141(199810)28:10<3066::AID-IMMU3066>3.0.CO;2-2

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes.

Authors:  C Dupuy; D Buzoni-Gatel; A Touzé; D Bout; P Coursaget
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Mucosal immunization in macaques upregulates the innate APOBEC 3G anti-viral factor in CD4(+) memory T cells.

Authors:  Yufei Wang; Lesley A Bergmeier; Richard Stebbings; Thomas Seidl; Trevor Whittall; Mahavir Singh; Neil Berry; Neil Almond; Thomas Lehner
Journal:  Vaccine       Date:  2008-12-11       Impact factor: 3.641

3.  Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.

Authors:  M Magdalena Gherardi; José Luis Nájera; Eva Pérez-Jiménez; Susana Guerra; Adolfo García-Sastre; Mariano Esteban
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

4.  Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virus.

Authors:  Bruno Garulli; Yoshihiro Kawaoka; Maria R Castrucci
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

5.  The development of an AIDS mucosal vaccine.

Authors:  Xian Tang; Zhiwei Chen
Journal:  Viruses       Date:  2010-01-22       Impact factor: 5.818

6.  Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses.

Authors:  Paul F McKay; Jamie F S Mann; Aditya Pattani; Vicky Kett; Yoann Aldon; Deborah King; R Karl Malcolm; Robin J Shattock
Journal:  J Control Release       Date:  2017-01-21       Impact factor: 9.776

Review 7.  Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.

Authors:  Jose Rey-Ladino; Allen G P Ross; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.